Table 1.
C4d staining in immune complex-mediated GN
Patient | Pathology Diagnosis | C4d | C3 | C1q | Ig |
---|---|---|---|---|---|
1 | Chronic MPGN, monoclonal gammopathy associated (κ light chains) | 1–2 | 3 | 0 | κ 3+negative IgG, IgM, IgA, λ |
2 | MPGN, hepatitis C associated | 2 | 3 | 0 | IgM 3+, IgG 2+, κ 3+, λ 2+ |
3 | MPGN, monoclonal gammopathy associated (IgM κ) | 3 | 3 | 0 | IgM 3+, κ 3+negative IgA, IgG |
4 | IgA nephropathy | 0 | 1 | 0 | IgA 3+, IgM 1+, κ 2+, λ 2+ |
5 | Lupus nephritis | 3 | 3 | 1 | IgA 2+, IgG 3+, IgM 2+, κ 3+, λ 3+ |
6 | Membranous nephropathy | 3 | 3 | 0 | IgG 3+, κ 3+, λ 3+ |
7 | Membranous nephropathy | 3 | 3 | 0 | IgG 3+, IgM 2+, κ 3+, λ 3+ |
8 | IgA nephropathy | 0 | 2 | 0 | IgA 3+, κ 2+, λ 3+ |
9 | Lupus nephritis | 3 | 3 | 2 | IgA 3+, IgG 3+, IgM 2+, κ 3+, λ 3+ |
10 | MPGN, autoimmune | 3 | 3 | 2 | IgG 3+, IgA 3+, IgM 3+, κ 3+, λ 3+ |
11 | Fibrillary GN | 3 | 3 | 0 | IgG 3+, κ 2+, λ 3+ |
12 | Membranous nephropathy | 2 | 3 | 0 | IgG 3+, κ 3+, λ 3+ |
13 | MPGN (C3GN versus immune complex-mediated) | 3 | 3 | 0 | IgG 1+, κ 1+ |
14 | Lupus membranous, early | 2 | 3 | 0 | IgG 3+, κ 2–3+, λ 2–3+ |
15 | Membranous nephropathy | 2 | 3 | 0 | IgG 3+, κ 3+, λ 3+ |
16 | Lupus nephritis | 3 | 3 | 3 | IgA 3+, IgG 3+, IgM 1+, κ 3+, λ 3+ |
17 | Lupus nephritis | 3 | 2 | 3 | IgA 3+, IgG 3+, IgM 2+, κ 3+, λ 3+ |
18 | Fibrillary GN | 3 | 3 | 0 | IgG 3+, κ 2+, λ 3+ |